Atlantic Healthcare

15 articles about Atlantic Healthcare

• Atlantic Healthcare Appoints Finance Industry Veteran Andrew Jones to Board of Directors

  2/19/2020

  Atlantic Healthcare plc announces the appointment of Andrew Jones as a non-executive director, bringing more than 25 years of international capital market experience in New York, London & Hong Kong to the Board Of Directors.

• Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen

  1/31/2020

  Atlantic Healthcare plc, a specialist pharmaceutical company focused on acquiring, developing and commercializing therapeutics that address unmet patient needs and rare diseases, with a focus on gastroenterology hosted a Key Opinion Leader event on the current treatment landscape and unmet medical need in Ulcerative Colitis.

• Atlantic Healthcare to present at JPM / Biotech Showcase 13-15 January 2020, San Francisco, USA

  12/17/2019

  Atlantic Healthcare plc, a specialist pharmaceutical company focused on acquiring, developing and commercialising therapeutics that address unmet patient needs and rare diseases, announces it will present at the Biotech Showcase conference, held in San Francisco from January 13-15, 2020.

• Atlantic Healthcare to Present at the Biotech Showcase

  12/17/2019

  Atlantic Healthcare plc (“Atlantic Healthcare” or “Company”), a specialist pharmaceutical company focused on acquiring, developing and commercialising therapeutics that address unmet patient needs and rare diseases, today announces it will present at the Biotech Showcase conference, held in San Francisco from January 13-15, 2020.

• Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis

  7/31/2019

  Atlantic Healthcare plc, a specialist pharmaceutical company focused on acquiring, developing and commercializing therapeutics that address unmet patient needs and rare diseases, announced the results of the Phase 3 trial of Camligo™ for orphan-designated pouchitis.

• Atlantic Healthcare plc acquires global rights to renzapride for the treatment of gastrointestinal motility disorders

  6/26/2019

  Renzapride is a clinical stage product, which we believe has wide applicability for the treatment of motility disorders of the gastrointestinal (GI) tract, many of which represent significant unmet medical needs.

• Atlantic Healthcare reports results from Phase 1 trial of tablet for Crohn’s

  9/27/2018

  Oral alicaforsen appears safe and well-tolerated

• Atlantic Healthcare secures acceptance of brand name Camligo™  for alicaforsen enema to treat pouchitis

  9/14/2018

  Atlantic Healthcare plc has secured acceptance of Camligo™ as the name for the Company’s first candidate product.

• Strategic appointment expands Atlantic Healthcare executive team

  8/2/2018

  Atlantic Healthcare plc (Atlantic Healthcare), a specialist gastrointestinal (GI) pharmaceutical company, developing treatments for inflammatory bowel disease and other GI diseases, has appointed John Temperato as U.S. President and Chief Operating Officer, to lead the commercialisation programme of alicaforsen in the U.S.

• Atlantic Healthcare Develops Tablet Formulations Of Alicaforsen To Treat Crohn's Disease And Ulcerative Colitis

  5/30/2017

• Atlantic Healthcare Announces Strengthening Of The Board As It Prepares For Commercialisation Of Alicaforsen In Its First Indication

  5/22/2017

• Atlantic Healthcare Initiates FDA Rolling Submission Of Its New Drug Application For Alicaforsen In The Treatment Of Pouchitis

  5/1/2017

• Atlantic Healthcare Confirms Alicaforsen Targets TLR-9, Providing A Second Mechanism Of Action To Treat New And Existing Inflammatory Indications

  2/28/2017

• Atlantic Healthcare Release: Pharma Receives FDA Agreement To Initiate Rolling Submission Of Its New Drug Application For Alicaforsen In The Treatment Of Pouchitis

  1/24/2017

• Atlantic Healthcare Granted U.S. Patent Extending IP Cover Of Alicaforsen In The Treatment Of Inflammatory Bowel Disease

  11/7/2016